Effects of dexamethasone on prostacyclin biosynthesis in rabbit mesothelial cells

Prostaglandins. 1986 Aug;32(2):169-78. doi: 10.1016/0090-6980(86)90122-x.

Abstract

We investigated whether glucocorticoids reduce the formation of arachidonic acid metabolites in a non myeloid cell type, the mesothelial cell, which is functionally and embryologically related to the vascular endothelial cell and which forms almost exclusively prostacyclin from arachidonic acid. Preincubation of rabbit mesothelial cells with 2.5 microM dexamethasone suppressed basal as well as bradykinin- or thrombin-stimulated prostacyclin biosynthesis. In further experiments bradykinin was selected as stimulus. The inhibition by dexamethasone was dose-dependent between 0.025 and 2.5 microM. The minimum contact period required for expression of this effect was 30 min and after a contact period of 60 to 120 min the inhibition reached a maximum, but was never complete. After 240 min, sufficient activity was secreted in the extracellular medium for inhibition of the prostacyclin formation in untreated cells. Experiments with cycloheximide were somewhat confused by its direct effects on prostacyclin biosynthesis, but still suggested that the anti-prostacyclin effect of dexamethasone required de novo protein biosynthesis. Our experiments indicate that glucocorticoids induce the formation of lipocortin-like factor(s) in non-phagocytic mesothelial cells, thereby suppressing the formation of prostacyclin, their main arachidonic metabolite.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bradykinin / pharmacology
  • Cycloheximide / pharmacology
  • Dactinomycin / pharmacology
  • Dexamethasone / pharmacology*
  • Epoprostenol / biosynthesis*
  • In Vitro Techniques
  • Omentum / cytology
  • Omentum / drug effects*
  • Omentum / metabolism
  • Rabbits

Substances

  • Dactinomycin
  • Dexamethasone
  • Cycloheximide
  • Epoprostenol
  • Bradykinin